The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-5-methyl-3-phenylisoxazole-4-carbothioamide
ID: ALA4555416
PubChem CID: 155557188
Max Phase: Preclinical
Molecular Formula: C21H23N3OS
Molecular Weight: 365.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=S)c2c(-c3ccccc3)noc2C)cc1
Standard InChI: InChI=1S/C21H23N3OS/c1-4-24(5-2)18-13-11-17(12-14-18)22-21(26)19-15(3)25-23-20(19)16-9-7-6-8-10-16/h6-14H,4-5H2,1-3H3,(H,22,26)
Standard InChI Key: HFQCGCHUFPPBII-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.6183 -3.3415 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6121 -4.1628 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3910 -4.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8823 -3.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4010 -3.0972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6125 -2.3037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0307 -1.7216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2464 -0.9307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0400 -0.7192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6161 -1.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4093 -2.0913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6994 -3.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1028 -4.4804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.9199 -4.4865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3213 -5.1993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1377 -5.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5524 -4.5005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1447 -3.7874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3296 -3.7845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3696 -4.5055 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.7738 -5.2157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7825 -3.8003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5997 -3.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5910 -5.2207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6357 -5.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1133 -3.0651 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 5 1 0
7 6 2 0
8 7 1 0
9 8 2 0
10 9 1 0
11 10 2 0
6 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
20 22 1 0
22 23 1 0
21 24 1 0
3 25 1 0
12 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 365.50 | Molecular Weight (Monoisotopic): 365.1562 | AlogP: 5.28 | #Rotatable Bonds: 6 |
Polar Surface Area: 41.30 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.15 | CX Basic pKa: 5.64 | CX LogP: 5.37 | CX LogD: 5.37 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.60 | Np Likeness Score: -1.65 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |